Jiangsu Hengrui Medicine Co., Ltd.

This study tests a new experimental drug (HR070803) added to standard chemotherapy and targeted therapy for people with advanced colorectal cancer that has spread and cannot be removed by surgery. About 669 participants will receive either the new combo or standard treatment alon…

This study tests whether adding two drugs (camrelizumab and rivoceranib) to a standard liver cancer procedure (TACE) helps people with incurable liver cancer live longer without their cancer growing. About 423 adults with liver cancer that cannot be removed by surgery are taking …